• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

9 months ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

Other news

VanEck Cuts Management Fee for Spot Solana ETF to Attract Investors

chest

VanEck has amended its prospectus for a Spot Solana ETF, reducing the management fee to 0.30 to attract institutional investors.

user avatarRajesh Kumar

Ripple's CEO explains the difference between Ripple and XRP.

chest

Ripple CEO Brad Garlinghouse clarifies the distinction between Ripple and XRP, emphasizing that Ripple is a fintech company and XRP is a decentralized digital asset.

user avatarMiguel Rodriguez

Corporate Adoption of Cryptocurrencies Grows

chest

Companies are increasingly incorporating cryptocurrencies into their treasury portfolios, with Ethereum becoming a preferred asset.

user avatarDavid Robinson

Altcoins Fail to Rally Despite Crypto Highs in Q3 2025

chest

Altcoins failed to rally despite Bitcoin and Ethereum reaching new price levels in Q3 2025, leading to prolonged consolidation.

user avatarMaria Gutierrez

OpenTensor Foundation Resumes Subnet Registration to Boost Competition

chest

The OpenTensor Foundation has reinstated the subnet registration mechanism, capping the number of subnets at 128 to enhance competition and quality among subnet teams.

user avatarLuis Flores

Binance's Listing Standards Challenge Pi Network

chest

Binance's CEO emphasizes that project strength and transparency are key for listings, posing a challenge for Pi Network.

user avatarArif Mukhtar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.